1. Wang Y, Bellomo R. 2017; Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 13:697–711. DOI:
10.1038/nrneph.2017.119. PMID:
28869251.
Article
2. Albert C, Haase M, Albert A, Kropf S, Bellomo R, Westphal S, et al. 2020; Urinary Biomarkers may complement the Cleveland score for prediction of adverse kidney events after cardiac surgery: a pilot study. Ann Lab Med. 40:131–41. DOI:
10.3343/alm.2020.40.2.131. PMID:
31650729. PMCID:
PMC6822001.
Article
4. Albert C, Haase M, Albert A, Ernst M, Kropf S, Bellomo R, et al. 2021; Predictive value of plasma NGAL:hepcidin-25 for major adverse kidney events after cardiac surgery with cardiopulmonary bypass: a pilot study. Ann Lab Med. 41:357–65. DOI:
10.3343/alm.2021.41.4.357. PMID:
33536353.
Article
5. Haase-Fielitz A, Mertens PR, Plass M, Kuppe H, Hetzer R, Westerman M, et al. 2011; Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort study. Crit Care. 15:R186. DOI:
10.1186/cc10339. PMID:
21816077. PMCID:
PMC3387629.
Article
6. Choi N, Whitlock R, Klassen J, Zappitelli M, Arora RC, Rigatto C, Ho J, et al. 2019; Early intraoperative iron-binding proteins are associated with acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 157:287–97. e2. DOI:
10.1016/j.jtcvs.2018.06.091. PMID:
30195593.
Article